JPS58216125A - ヒト抗体の産生方法 - Google Patents

ヒト抗体の産生方法

Info

Publication number
JPS58216125A
JPS58216125A JP57097596A JP9759682A JPS58216125A JP S58216125 A JPS58216125 A JP S58216125A JP 57097596 A JP57097596 A JP 57097596A JP 9759682 A JP9759682 A JP 9759682A JP S58216125 A JPS58216125 A JP S58216125A
Authority
JP
Japan
Prior art keywords
cell
cells
cell line
human
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57097596A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0439999B2 (https=
Inventor
Tsutomu Abe
力 阿部
Hiromitsu Sakae
寒河江　洋充
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Priority to JP57097596A priority Critical patent/JPS58216125A/ja
Priority to DE8383105615T priority patent/DE3379055D1/de
Priority to EP83105615A priority patent/EP0096839B1/en
Publication of JPS58216125A publication Critical patent/JPS58216125A/ja
Priority to US06/750,199 priority patent/US4833077A/en
Publication of JPH0439999B2 publication Critical patent/JPH0439999B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP57097596A 1982-06-09 1982-06-09 ヒト抗体の産生方法 Granted JPS58216125A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP57097596A JPS58216125A (ja) 1982-06-09 1982-06-09 ヒト抗体の産生方法
DE8383105615T DE3379055D1 (en) 1982-06-09 1983-06-08 Method for producing human antibody
EP83105615A EP0096839B1 (en) 1982-06-09 1983-06-08 Method for producing human antibody
US06/750,199 US4833077A (en) 1982-06-09 1985-07-01 Method for producing human antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57097596A JPS58216125A (ja) 1982-06-09 1982-06-09 ヒト抗体の産生方法

Publications (2)

Publication Number Publication Date
JPS58216125A true JPS58216125A (ja) 1983-12-15
JPH0439999B2 JPH0439999B2 (https=) 1992-07-01

Family

ID=14196612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57097596A Granted JPS58216125A (ja) 1982-06-09 1982-06-09 ヒト抗体の産生方法

Country Status (1)

Country Link
JP (1) JPS58216125A (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133125A (ja) * 1984-07-25 1986-02-17 Morinaga & Co Ltd ヒト単クロ−ン性抗肺ガン細胞抗体
JPS6187630A (ja) * 1984-10-08 1986-05-06 Teijin Ltd 単純ヘルペスウイルスに対するヒトモノクロ−ナル抗体及びその製造法
JPS61155398A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 抗緑膿菌ヒトモノクロ−ナル抗体及びその製造法並びにそれを有効成分とする治療剤
JPS61204200A (ja) * 1984-09-26 1986-09-10 Sumitomo Chem Co Ltd ヒトモノクロ−ナル抗体およびその製法
JPS6272627A (ja) * 1985-09-27 1987-04-03 Teijin Ltd 単純ヘルペスウイルス感染症の予防又は治療剤
JPS62187417A (ja) * 1985-12-10 1987-08-15 ジエネテイツク　システムズ　コ−ポレ−シヨン 緑膿菌血清型に対する交さ反応性かつ交さ防御性単クロ−ン性抗体
JPS6467199A (en) * 1987-09-08 1989-03-13 Agency Ind Science Techn Human igg1 type monoclonal antibody, production thereof and hybridoma capable of producing said antibody
RU2709531C2 (ru) * 2010-05-28 2019-12-18 Ф. Хоффманн-Ля Рош Аг Способ культивирования одиночной в-клетки

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133125A (ja) * 1984-07-25 1986-02-17 Morinaga & Co Ltd ヒト単クロ−ン性抗肺ガン細胞抗体
JPS61204200A (ja) * 1984-09-26 1986-09-10 Sumitomo Chem Co Ltd ヒトモノクロ−ナル抗体およびその製法
JPS6187630A (ja) * 1984-10-08 1986-05-06 Teijin Ltd 単純ヘルペスウイルスに対するヒトモノクロ−ナル抗体及びその製造法
JPS61155398A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 抗緑膿菌ヒトモノクロ−ナル抗体及びその製造法並びにそれを有効成分とする治療剤
JPS6272627A (ja) * 1985-09-27 1987-04-03 Teijin Ltd 単純ヘルペスウイルス感染症の予防又は治療剤
JPS62187417A (ja) * 1985-12-10 1987-08-15 ジエネテイツク　システムズ　コ−ポレ−シヨン 緑膿菌血清型に対する交さ反応性かつ交さ防御性単クロ−ン性抗体
JPS6467199A (en) * 1987-09-08 1989-03-13 Agency Ind Science Techn Human igg1 type monoclonal antibody, production thereof and hybridoma capable of producing said antibody
RU2709531C2 (ru) * 2010-05-28 2019-12-18 Ф. Хоффманн-Ля Рош Аг Способ культивирования одиночной в-клетки

Also Published As

Publication number Publication date
JPH0439999B2 (https=) 1992-07-01

Similar Documents

Publication Publication Date Title
Muir et al. The preparation, isolation, and growth in culture of single cells from higher plants
Schuler et al. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.
Knight et al. Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology
Lake et al. Production and characterization of cytotoxic Thy‐1 antibody‐secreting hybrid cell lines Detection of T cell subsets
US4434230A (en) Human nonsecretory plasmacytoid cell line
Fellous et al. Induction of HLA expression in Daudi cells after cell fusion
Hesselton et al. Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution
FI75600C (fi) Foerfarande foer framstaellning av en monoklonal antikropp mot en maensklig monocytantigen medelst en ny hybridcellinje.
CA1229791A (fr) Composition medicamenteuse a base de fragments fc d'igg humaines
JPH0198478A (ja) ＩｇＧモノクローナル抗体−生産性ハイブリドマ
EP0093436B1 (de) Verfahren zur Herstellung permanenter tierischer und humaner Zellinien und deren Verwendung
JPS59169489A (ja) ヒト培養株化細胞
Bartal et al. Methods of hybridoma formation
JPH03501804A (ja) ヒトｔリンパ球のｌｆａ‐１抗原の新規なエピトープに特異的なモノクローナル抗体
JPS5829714A (ja) 血清不含およびミトゲン不含ｔ細胞生長因子およびその製造法
US4100022A (en) Process for preparing a curing agent for myelogenic leukemia
JPS58216125A (ja) ヒト抗体の産生方法
Borland et al. Early appearance of “transformed” cells from the kidneys of rats treated with a “single” carcinogenic dose of dimethylnitrosamine (DMN) detected by culture in vitro
DE3786673T2 (de) Verfahren zur entfernung unerwünschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikörper und dafür geeigneter kit.
CA1213227A (en) Human nonsecretory plasmacytoid cell line
KR20090010053A (ko) 융합 파트너 세포
EP0096839B1 (en) Method for producing human antibody
JPS59175896A (ja) ヒト抗体産生方法
UEDA et al. DIFFERENTIAL EFFECTS OF INTERLEUKIN 2 RECEPTOR-TARGETED THERAPY ON HEART AND KIDNEY ALLOGRAFTS IN RATS: DEPRESSION OF EFFECTIVENESS OF ART-18 MONOCLONAL ANTIBODY TREATMENT BY UREMIA
Papageorge et al. Expression of the defective “S+ L−” type murine sarcoma virus genome in human amnion and lung cells